The multi-Siglec inhibitor AL009 reprograms suppressive macrophages and activates innate and adaptive tumor immunity
S. C. Nalle, H. Lam, L. Leung, S. Liang, D. Maslyar, A. Rosenthal
AL009, a multi-Siglec inhibitor, reprograms suppressive macrophages and enhances anti-tumor immunity in preclinical models.
bioRxiv · Aug 2, 2023 · PreprintCancer Biology